BETHESDA, Md. -- Regulatory and scientific issues facing the generic pharmaceutical industry will be discussed when the National Association of Pharmaceutical Manufacturers (NAPM) holds its fall workshop October 11 through October 13 at the Hyatt Regency here.
The meeting will provide a forum in which NAPM members can meet with representatives of the Food and Drug Administration, the United States Pharmacopeia (USP) and other organizations, says NAPM president Robert Milanese.
"This workshop will bring regulators and the industry together so that the regulatory approval process for generic drug products is both strengthened and streamlined to ensure timely …
No comments:
Post a Comment